Search

Your search keyword '"El-Hariry, Iman A."' showing total 89 results
Start Over Author "El-Hariry, Iman A." Database Unpaywall
89 results on '"El-Hariry, Iman A."'

1. A phase I dose escalation study of eryaspase in combination with modified FOLFIRINOX in locally advanced and metastatic pancreatic ductal adenocarcinoma.

Author

Yin, Chao, primary, Marshall, John, additional, Macke, Laura Ann, additional, He, Aiwu Ruth, additional, Bouker, Kerrie, additional, Weinberg, Benjamin Adam, additional, Mukherji, Reetu, additional, Weiner, Louis M., additional, Wang, Hongkun, additional, Geng, Xue, additional, Hoke, Frank, additional, Youssoufian, Hagop, additional, El-Hariry, Iman, additional, and Noel, Marcus Smith, additional

Published
2023
Full Text
View/download PDF

2. Data from Targeted Inhibition of the Molecular Chaperone Hsp90 Overcomes ALK Inhibitor Resistance in Non–Small Cell Lung Cancer

Author

Sang, Jim, primary, Acquaviva, Jaime, primary, Friedland, Julie C., primary, Smith, Donald L., primary, Sequeira, Manuel, primary, Zhang, Chaohua, primary, Jiang, Qin, primary, Xue, Liquan, primary, Lovly, Christine M., primary, Jimenez, John-Paul, primary, Shaw, Alice T., primary, Doebele, Robert C., primary, He, Suqin, primary, Bates, Richard C., primary, Camidge, D. Ross, primary, Morris, Stephan W., primary, El-Hariry, Iman, primary, and Proia, David A., primary

Published
2023
Full Text
View/download PDF

3. Data from Targeted Inhibition of the Molecular Chaperone Hsp90 Overcomes ALK Inhibitor Resistance in Non–Small Cell Lung Cancer

Author

Sang, Jim, primary, Acquaviva, Jaime, primary, Friedland, Julie C., primary, Smith, Donald L., primary, Sequeira, Manuel, primary, Zhang, Chaohua, primary, Jiang, Qin, primary, Xue, Liquan, primary, Lovly, Christine M., primary, Jimenez, John-Paul, primary, Shaw, Alice T., primary, Doebele, Robert C., primary, He, Suqin, primary, Bates, Richard C., primary, Camidge, D. Ross, primary, Morris, Stephan W., primary, El-Hariry, Iman, primary, and Proia, David A., primary

Published
2023
Full Text
View/download PDF

4. Supplementary Figure 2 from Targeted Inhibition of the Molecular Chaperone Hsp90 Overcomes ALK Inhibitor Resistance in Non–Small Cell Lung Cancer

Author

Sang, Jim, primary, Acquaviva, Jaime, primary, Friedland, Julie C., primary, Smith, Donald L., primary, Sequeira, Manuel, primary, Zhang, Chaohua, primary, Jiang, Qin, primary, Xue, Liquan, primary, Lovly, Christine M., primary, Jimenez, John-Paul, primary, Shaw, Alice T., primary, Doebele, Robert C., primary, He, Suqin, primary, Bates, Richard C., primary, Camidge, D. Ross, primary, Morris, Stephan W., primary, El-Hariry, Iman, primary, and Proia, David A., primary

Published
2023
Full Text
View/download PDF

5. Supplementary Figure 1 from Targeted Inhibition of the Molecular Chaperone Hsp90 Overcomes ALK Inhibitor Resistance in Non–Small Cell Lung Cancer

Author

Sang, Jim, primary, Acquaviva, Jaime, primary, Friedland, Julie C., primary, Smith, Donald L., primary, Sequeira, Manuel, primary, Zhang, Chaohua, primary, Jiang, Qin, primary, Xue, Liquan, primary, Lovly, Christine M., primary, Jimenez, John-Paul, primary, Shaw, Alice T., primary, Doebele, Robert C., primary, He, Suqin, primary, Bates, Richard C., primary, Camidge, D. Ross, primary, Morris, Stephan W., primary, El-Hariry, Iman, primary, and Proia, David A., primary

Published
2023
Full Text
View/download PDF

6. Supplementary Figure 4 from Targeted Inhibition of the Molecular Chaperone Hsp90 Overcomes ALK Inhibitor Resistance in Non–Small Cell Lung Cancer

Author

Sang, Jim, primary, Acquaviva, Jaime, primary, Friedland, Julie C., primary, Smith, Donald L., primary, Sequeira, Manuel, primary, Zhang, Chaohua, primary, Jiang, Qin, primary, Xue, Liquan, primary, Lovly, Christine M., primary, Jimenez, John-Paul, primary, Shaw, Alice T., primary, Doebele, Robert C., primary, He, Suqin, primary, Bates, Richard C., primary, Camidge, D. Ross, primary, Morris, Stephan W., primary, El-Hariry, Iman, primary, and Proia, David A., primary

Published
2023
Full Text
View/download PDF

7. Supplementary Methods and Figure Legends from Targeted Inhibition of the Molecular Chaperone Hsp90 Overcomes ALK Inhibitor Resistance in Non–Small Cell Lung Cancer

Author

Sang, Jim, primary, Acquaviva, Jaime, primary, Friedland, Julie C., primary, Smith, Donald L., primary, Sequeira, Manuel, primary, Zhang, Chaohua, primary, Jiang, Qin, primary, Xue, Liquan, primary, Lovly, Christine M., primary, Jimenez, John-Paul, primary, Shaw, Alice T., primary, Doebele, Robert C., primary, He, Suqin, primary, Bates, Richard C., primary, Camidge, D. Ross, primary, Morris, Stephan W., primary, El-Hariry, Iman, primary, and Proia, David A., primary

Published
2023
Full Text
View/download PDF

8. Supplementary Methods and Figure Legends from Targeted Inhibition of the Molecular Chaperone Hsp90 Overcomes ALK Inhibitor Resistance in Non–Small Cell Lung Cancer

Author

Sang, Jim, primary, Acquaviva, Jaime, primary, Friedland, Julie C., primary, Smith, Donald L., primary, Sequeira, Manuel, primary, Zhang, Chaohua, primary, Jiang, Qin, primary, Xue, Liquan, primary, Lovly, Christine M., primary, Jimenez, John-Paul, primary, Shaw, Alice T., primary, Doebele, Robert C., primary, He, Suqin, primary, Bates, Richard C., primary, Camidge, D. Ross, primary, Morris, Stephan W., primary, El-Hariry, Iman, primary, and Proia, David A., primary

Published
2023
Full Text
View/download PDF

9. Supplementary Figure 1 from Targeted Inhibition of the Molecular Chaperone Hsp90 Overcomes ALK Inhibitor Resistance in Non–Small Cell Lung Cancer

Author

Sang, Jim, primary, Acquaviva, Jaime, primary, Friedland, Julie C., primary, Smith, Donald L., primary, Sequeira, Manuel, primary, Zhang, Chaohua, primary, Jiang, Qin, primary, Xue, Liquan, primary, Lovly, Christine M., primary, Jimenez, John-Paul, primary, Shaw, Alice T., primary, Doebele, Robert C., primary, He, Suqin, primary, Bates, Richard C., primary, Camidge, D. Ross, primary, Morris, Stephan W., primary, El-Hariry, Iman, primary, and Proia, David A., primary

Published
2023
Full Text
View/download PDF

10. Supplementary Figure 4 from Targeted Inhibition of the Molecular Chaperone Hsp90 Overcomes ALK Inhibitor Resistance in Non–Small Cell Lung Cancer

Author

Sang, Jim, primary, Acquaviva, Jaime, primary, Friedland, Julie C., primary, Smith, Donald L., primary, Sequeira, Manuel, primary, Zhang, Chaohua, primary, Jiang, Qin, primary, Xue, Liquan, primary, Lovly, Christine M., primary, Jimenez, John-Paul, primary, Shaw, Alice T., primary, Doebele, Robert C., primary, He, Suqin, primary, Bates, Richard C., primary, Camidge, D. Ross, primary, Morris, Stephan W., primary, El-Hariry, Iman, primary, and Proia, David A., primary

Published
2023
Full Text
View/download PDF

11. Supplementary Figure 3 from Targeted Inhibition of the Molecular Chaperone Hsp90 Overcomes ALK Inhibitor Resistance in Non–Small Cell Lung Cancer

Author

Sang, Jim, primary, Acquaviva, Jaime, primary, Friedland, Julie C., primary, Smith, Donald L., primary, Sequeira, Manuel, primary, Zhang, Chaohua, primary, Jiang, Qin, primary, Xue, Liquan, primary, Lovly, Christine M., primary, Jimenez, John-Paul, primary, Shaw, Alice T., primary, Doebele, Robert C., primary, He, Suqin, primary, Bates, Richard C., primary, Camidge, D. Ross, primary, Morris, Stephan W., primary, El-Hariry, Iman, primary, and Proia, David A., primary

Published
2023
Full Text
View/download PDF

12. Supplementary Figure 3 from Targeted Inhibition of the Molecular Chaperone Hsp90 Overcomes ALK Inhibitor Resistance in Non–Small Cell Lung Cancer

Author

Sang, Jim, primary, Acquaviva, Jaime, primary, Friedland, Julie C., primary, Smith, Donald L., primary, Sequeira, Manuel, primary, Zhang, Chaohua, primary, Jiang, Qin, primary, Xue, Liquan, primary, Lovly, Christine M., primary, Jimenez, John-Paul, primary, Shaw, Alice T., primary, Doebele, Robert C., primary, He, Suqin, primary, Bates, Richard C., primary, Camidge, D. Ross, primary, Morris, Stephan W., primary, El-Hariry, Iman, primary, and Proia, David A., primary

Published
2023
Full Text
View/download PDF

13. Supplementary Figure 2 from Targeted Inhibition of the Molecular Chaperone Hsp90 Overcomes ALK Inhibitor Resistance in Non–Small Cell Lung Cancer

Author

Sang, Jim, primary, Acquaviva, Jaime, primary, Friedland, Julie C., primary, Smith, Donald L., primary, Sequeira, Manuel, primary, Zhang, Chaohua, primary, Jiang, Qin, primary, Xue, Liquan, primary, Lovly, Christine M., primary, Jimenez, John-Paul, primary, Shaw, Alice T., primary, Doebele, Robert C., primary, He, Suqin, primary, Bates, Richard C., primary, Camidge, D. Ross, primary, Morris, Stephan W., primary, El-Hariry, Iman, primary, and Proia, David A., primary

Published
2023
Full Text
View/download PDF

14. Supplementary Figure 1 from Preclinical Activity Profile and Therapeutic Efficacy of the HSP90 Inhibitor Ganetespib in Triple-Negative Breast Cancer

Author

Proia, David A., primary, Zhang, Chaohua, primary, Sequeira, Manuel, primary, Jimenez, John-Paul, primary, He, Suqin, primary, Spector, Neil, primary, Shapiro, Geoffrey I., primary, Tolaney, Sara, primary, Nagai, Masazumi, primary, Acquaviva, Jaime, primary, Smith, Donald L., primary, Sang, Jim, primary, Bates, Richard C., primary, and El-Hariry, Iman, primary

Published
2023
Full Text
View/download PDF

15. Supplementary Figure 1 from Preclinical Activity Profile and Therapeutic Efficacy of the HSP90 Inhibitor Ganetespib in Triple-Negative Breast Cancer

Author

Proia, David A., primary, Zhang, Chaohua, primary, Sequeira, Manuel, primary, Jimenez, John-Paul, primary, He, Suqin, primary, Spector, Neil, primary, Shapiro, Geoffrey I., primary, Tolaney, Sara, primary, Nagai, Masazumi, primary, Acquaviva, Jaime, primary, Smith, Donald L., primary, Sang, Jim, primary, Bates, Richard C., primary, and El-Hariry, Iman, primary

Published
2023
Full Text
View/download PDF

16. Supplementary Figure 4 from Preclinical Activity Profile and Therapeutic Efficacy of the HSP90 Inhibitor Ganetespib in Triple-Negative Breast Cancer

Author

Proia, David A., primary, Zhang, Chaohua, primary, Sequeira, Manuel, primary, Jimenez, John-Paul, primary, He, Suqin, primary, Spector, Neil, primary, Shapiro, Geoffrey I., primary, Tolaney, Sara, primary, Nagai, Masazumi, primary, Acquaviva, Jaime, primary, Smith, Donald L., primary, Sang, Jim, primary, Bates, Richard C., primary, and El-Hariry, Iman, primary

Published
2023
Full Text
View/download PDF

17. Supplementary Methods from A Multicenter Phase II Study of Ganetespib Monotherapy in Patients with Genotypically Defined Advanced Non–Small Cell Lung Cancer

Author

Socinski, Mark A., primary, Goldman, Jonathan, primary, El-Hariry, Iman, primary, Koczywas, Marianna, primary, Vukovic, Vojo, primary, Horn, Leora, primary, Paschold, Eugene, primary, Salgia, Ravi, primary, West, Howard, primary, Sequist, Lecia V., primary, Bonomi, Philip, primary, Brahmer, Julie, primary, Chen, Lin-Chi, primary, Sandler, Alan, primary, Belani, Chandra P., primary, Webb, Timothy, primary, Harper, Harry, primary, Huberman, Mark, primary, Ramalingam, Suresh, primary, Wong, Kwok-Kin, primary, Teofilovici, Florentina, primary, Guo, Wei, primary, and Shapiro, Geoffrey I., primary

Published
2023
Full Text
View/download PDF

18. Supplementary Methods from A Multicenter Phase II Study of Ganetespib Monotherapy in Patients with Genotypically Defined Advanced Non–Small Cell Lung Cancer

Author

Socinski, Mark A., primary, Goldman, Jonathan, primary, El-Hariry, Iman, primary, Koczywas, Marianna, primary, Vukovic, Vojo, primary, Horn, Leora, primary, Paschold, Eugene, primary, Salgia, Ravi, primary, West, Howard, primary, Sequist, Lecia V., primary, Bonomi, Philip, primary, Brahmer, Julie, primary, Chen, Lin-Chi, primary, Sandler, Alan, primary, Belani, Chandra P., primary, Webb, Timothy, primary, Harper, Harry, primary, Huberman, Mark, primary, Ramalingam, Suresh, primary, Wong, Kwok-Kin, primary, Teofilovici, Florentina, primary, Guo, Wei, primary, and Shapiro, Geoffrey I., primary

Published
2023
Full Text
View/download PDF

19. Supplementary Methods, Figure Legend from Preclinical Activity Profile and Therapeutic Efficacy of the HSP90 Inhibitor Ganetespib in Triple-Negative Breast Cancer

Author

Proia, David A., primary, Zhang, Chaohua, primary, Sequeira, Manuel, primary, Jimenez, John-Paul, primary, He, Suqin, primary, Spector, Neil, primary, Shapiro, Geoffrey I., primary, Tolaney, Sara, primary, Nagai, Masazumi, primary, Acquaviva, Jaime, primary, Smith, Donald L., primary, Sang, Jim, primary, Bates, Richard C., primary, and El-Hariry, Iman, primary

Published
2023
Full Text
View/download PDF

20. Supplementary Table 1 from Preclinical Activity Profile and Therapeutic Efficacy of the HSP90 Inhibitor Ganetespib in Triple-Negative Breast Cancer

Author

Proia, David A., primary, Zhang, Chaohua, primary, Sequeira, Manuel, primary, Jimenez, John-Paul, primary, He, Suqin, primary, Spector, Neil, primary, Shapiro, Geoffrey I., primary, Tolaney, Sara, primary, Nagai, Masazumi, primary, Acquaviva, Jaime, primary, Smith, Donald L., primary, Sang, Jim, primary, Bates, Richard C., primary, and El-Hariry, Iman, primary

Published
2023
Full Text
View/download PDF

21. Supplementary Figure 3 from Preclinical Activity Profile and Therapeutic Efficacy of the HSP90 Inhibitor Ganetespib in Triple-Negative Breast Cancer

Author

Proia, David A., primary, Zhang, Chaohua, primary, Sequeira, Manuel, primary, Jimenez, John-Paul, primary, He, Suqin, primary, Spector, Neil, primary, Shapiro, Geoffrey I., primary, Tolaney, Sara, primary, Nagai, Masazumi, primary, Acquaviva, Jaime, primary, Smith, Donald L., primary, Sang, Jim, primary, Bates, Richard C., primary, and El-Hariry, Iman, primary

Published
2023
Full Text
View/download PDF

22. Supplementary Figure 4 from Preclinical Activity Profile and Therapeutic Efficacy of the HSP90 Inhibitor Ganetespib in Triple-Negative Breast Cancer

Author

Proia, David A., primary, Zhang, Chaohua, primary, Sequeira, Manuel, primary, Jimenez, John-Paul, primary, He, Suqin, primary, Spector, Neil, primary, Shapiro, Geoffrey I., primary, Tolaney, Sara, primary, Nagai, Masazumi, primary, Acquaviva, Jaime, primary, Smith, Donald L., primary, Sang, Jim, primary, Bates, Richard C., primary, and El-Hariry, Iman, primary

Published
2023
Full Text
View/download PDF

23. Supplementary Figure 2 from Preclinical Activity Profile and Therapeutic Efficacy of the HSP90 Inhibitor Ganetespib in Triple-Negative Breast Cancer

Author

Proia, David A., primary, Zhang, Chaohua, primary, Sequeira, Manuel, primary, Jimenez, John-Paul, primary, He, Suqin, primary, Spector, Neil, primary, Shapiro, Geoffrey I., primary, Tolaney, Sara, primary, Nagai, Masazumi, primary, Acquaviva, Jaime, primary, Smith, Donald L., primary, Sang, Jim, primary, Bates, Richard C., primary, and El-Hariry, Iman, primary

Published
2023
Full Text
View/download PDF

24. Supplementary Figure 3 from Preclinical Activity Profile and Therapeutic Efficacy of the HSP90 Inhibitor Ganetespib in Triple-Negative Breast Cancer

Author

Proia, David A., primary, Zhang, Chaohua, primary, Sequeira, Manuel, primary, Jimenez, John-Paul, primary, He, Suqin, primary, Spector, Neil, primary, Shapiro, Geoffrey I., primary, Tolaney, Sara, primary, Nagai, Masazumi, primary, Acquaviva, Jaime, primary, Smith, Donald L., primary, Sang, Jim, primary, Bates, Richard C., primary, and El-Hariry, Iman, primary

Published
2023
Full Text
View/download PDF

25. Supplementary Methods, Figure Legend from Preclinical Activity Profile and Therapeutic Efficacy of the HSP90 Inhibitor Ganetespib in Triple-Negative Breast Cancer

Author

Proia, David A., primary, Zhang, Chaohua, primary, Sequeira, Manuel, primary, Jimenez, John-Paul, primary, He, Suqin, primary, Spector, Neil, primary, Shapiro, Geoffrey I., primary, Tolaney, Sara, primary, Nagai, Masazumi, primary, Acquaviva, Jaime, primary, Smith, Donald L., primary, Sang, Jim, primary, Bates, Richard C., primary, and El-Hariry, Iman, primary

Published
2023
Full Text
View/download PDF

26. Supplementary Figure 2 from Preclinical Activity Profile and Therapeutic Efficacy of the HSP90 Inhibitor Ganetespib in Triple-Negative Breast Cancer

Author

Proia, David A., primary, Zhang, Chaohua, primary, Sequeira, Manuel, primary, Jimenez, John-Paul, primary, He, Suqin, primary, Spector, Neil, primary, Shapiro, Geoffrey I., primary, Tolaney, Sara, primary, Nagai, Masazumi, primary, Acquaviva, Jaime, primary, Smith, Donald L., primary, Sang, Jim, primary, Bates, Richard C., primary, and El-Hariry, Iman, primary

Published
2023
Full Text
View/download PDF

27. Supplementary Table 1 from Preclinical Activity Profile and Therapeutic Efficacy of the HSP90 Inhibitor Ganetespib in Triple-Negative Breast Cancer

Author

Proia, David A., primary, Zhang, Chaohua, primary, Sequeira, Manuel, primary, Jimenez, John-Paul, primary, He, Suqin, primary, Spector, Neil, primary, Shapiro, Geoffrey I., primary, Tolaney, Sara, primary, Nagai, Masazumi, primary, Acquaviva, Jaime, primary, Smith, Donald L., primary, Sang, Jim, primary, Bates, Richard C., primary, and El-Hariry, Iman, primary

Published
2023
Full Text
View/download PDF

29. Trybeca-1: A randomized, phase 3 study of eryaspase in combination with chemotherapy versus chemotherapy alone as second-line treatment in patients with advanced pancreatic adenocarcinoma (NCT03665441).

Author

Hammel, Pascal, primary, El-Hariry, Iman, additional, Macarulla, Teresa, additional, Garcia-Carbonero, Rocio, additional, Metges, Jean-Philippe, additional, Bouché, Olivier, additional, Portales, Fabienne, additional, Pazo Cid, Roberto A., additional, Mineur, Laurent, additional, Cubillo Gracian, Antonio Manuel, additional, Trouilloud, Isabelle, additional, Guimbaud, Rosine, additional, Tougeron, David, additional, Reina Zoilo, Juan Jose, additional, Feliu, Jaime, additional, Sauri, Tamara, additional, Fountzilas, Christos, additional, Kay, Richard, additional, Youssoufian, Hagop, additional, and Hidalgo, Manuel, additional

Published
2022
Full Text
View/download PDF

30. A phase I dose-escalation study of eryaspase in combination with modified FOLFIRINOX in locally advanced and metastatic pancreatic ductal adenocarcinoma: Interim update.

Author

Yin, Chao, primary, Marshall, John, additional, Macke, Laura, additional, Bouker, Kerrie, additional, He, Aiwu Ruth, additional, Weinberg, Benjamin Adam, additional, Weiner, Louis M., additional, Wang, Hongkun, additional, Badri, Nabeel, additional, Biswas-Baldwin, Nigel, additional, Hoke, Frank, additional, Youssoufian, Hagop, additional, El-Hariry, Iman, additional, and Noel, Marcus Smith, additional

Published
2022
Full Text
View/download PDF

31. Expanded Access Program: Evaluating Safety of Erythrocytes Encapsulating L-Asparaginase in Combination with Polychemotherapy in Patients Under 55 Years Old with Acute Lymphoblastic Leukaemia (ALL) at Risk to Receive Other Formulations of Asparaginase

Author

Bertrand, Yves, primary, Boissel, Nicolas, additional, Schmitt, Claudine, additional, Villate, Alban, additional, Gyan, Emmanuel, additional, Quesnel, Bruno, additional, Recher, Christian, additional, Simon, Pauline, additional, Cheikh, Nathalie, additional, Poirée, Marilyne, additional, Stephan, Jean, additional, Dumesnil, Cecile, additional, and El-Hariry, Iman, additional

Published
2021
Full Text
View/download PDF

32. A phase I dose escalation study of eryaspase in combination with modified FOLFIRINOX in locally advanced and metastatic pancreatic ductal adenocarcinoma.

Author

Noel, Marcus Smith, primary, Philip, Philip Agop, additional, Tejani, Mohamedtaki Abdulaziz, additional, Marshall, John, additional, He, Aiwu Ruth, additional, Weinberg, Benjamin Adam, additional, Weiner, Louis M., additional, Biswas-Baldwin, Nigel, additional, Hoke, Frank, additional, Youssoufian, Hagop, additional, and El-Hariry, Iman, additional

Published
2021
Full Text
View/download PDF

34. TRYbeCA-1: A randomized, phase III study of eryaspase in combination with chemotherapy versus chemotherapy alone as second-line treatment in patients with pancreatic adenocarcinoma (NCT03665441).

Author

Hammel, Pascal, primary, Berardi, Rossana, additional, Creemers, Geert-Yan, additional, Cubillo, Antonio, additional, Van Cutsem, Eric, additional, Greil, Richard, additional, Macarulla, Teresa, additional, Metges, Jean-Philippe, additional, Noel, Marcus Smith, additional, Nygren, Peter, additional, Osterlund, Pia J., additional, Seufferlein, Thomas, additional, Wasan, Harpreet Singh, additional, Gupta, Anu, additional, Grummer, Linda Marie, additional, Biswas-Baldwin, Nigel, additional, Kay, Richard, additional, Youssoufian, Hagop, additional, El-Hariry, Iman, additional, and Hidalgo, Manuel, additional

Published
2020
Full Text
View/download PDF

35. Circulating tumor DNA is prognostic and potentially predictive of eryaspase efficacy in patients with advanced pancreatic adenocarcinoma.

Author

Bachet, Jean-Baptiste, primary, Blons, Helene, additional, Hammel, Pascal, additional, El Hariry, Iman, additional, Portales, Fabienne, additional, Mineur, Laurent, additional, Metges, Jean-Philippe, additional, Mulot, Claire, additional, Bourreau, Camille, additional, Cain, Jason, additional, Cros, Jerome, additional, and Laurent-Puig, Pierre, additional

Published
2020
Full Text
View/download PDF

36. Erratum to ‘Erythrocyte-encapsulated asparaginase (eryaspase) combined with chemotherapy in second-line treatment of advanced pancreatic cancer: An open-label, randomized Phase IIb trial’ [European Journal of Cancer, Volume 124 (January 2020) Pages 91-101]

Author

Hammel, Pascal, primary, Portales, Fabienne, additional, Mineur, Laurent, additional, Metges, Jean-Philippe, additional, Andre, Thierry, additional, De La Fouchardiere, Christelle, additional, Louvet, Christophe, additional, El Hajbi, Farid, additional, Faroux, Roger, additional, Guimbaud, Rosine, additional, Tougeron, David, additional, Bouche, Olivier, additional, Lecomte, Thierry, additional, Rebischung, Christine, additional, Tournigand, Christophe, additional, Cros, Jerome, additional, Kay, Richard, additional, Hamm, Adam, additional, Gupta, Anu, additional, Bachet, Jean-Baptiste, additional, and El Hariry, Iman, additional

Published
2020
Full Text
View/download PDF

37. Abstract OT1-08-02: TRYbeCA-2: A randomized phase 2/3 study of eryaspase in combination with gemcitabine and carboplatin chemotherapy versus chemotherapy alone as first-line treatment in patients with metastatic or locally recurrent triple-negative breast cancer (NCT03674242)

Author

Awada, Ahmad, primary, Cortes, Javier, additional, Slater, Sarah, additional, MacPherson, Iain, additional, Csoszi, Tibor, additional, Bertrand, Jean-Baptiste, additional, Clermont, Anne-Sophie, additional, Pollard, Rachel, additional, Chrestia-Blanchine, Romain, additional, Biswas-Baldwin, Nigel, additional, Youssoufian, Hagop, additional, and El-Hariry, Iman, additional

Published
2020
Full Text
View/download PDF

38. TRYbeCA-1: A randomized, phase III study of eryaspase in combination with chemotherapy versus chemotherapy alone as second-line treatment in patients with pancreatic adenocarcinoma (NCT03665441).

Author

Hammel, Pascal, primary, Berardi, Rossana, additional, Van Cutsem, Eric, additional, Feliu, Jaime, additional, Greil, Richard, additional, Wasan, Harpreet Singh, additional, Metges, Jean-Philippe, additional, Nygren, Peter, additional, Osterlund, Pia J., additional, Noel, Marcus Smith, additional, Seufferlein, Thomas, additional, Creemers, Geert-Yan, additional, Gupta, Anu, additional, Salesse, Sophie, additional, Biswas-Baldwin, Nigel, additional, Dion, Hedy, additional, Youssoufian, Hagop, additional, Garzon, Felix Tomas, additional, El-Hariry, Iman, additional, and Hidalgo, Manuel, additional

Published
2020
Full Text
View/download PDF

40. Erythrocyte-encapsulated asparaginase (eryaspase) combined with chemotherapy in second-line treatment of advanced pancreatic cancer: An open-label, randomized Phase IIb trial

Author

Hammel, Pascal, primary, Fabienne, Portales, additional, Mineur, Laurent, additional, Metges, Jean-Philippe, additional, Andre, Thierry, additional, De La Fouchardiere, Christelle, additional, Louvet, Christophe, additional, El Hajbi, Farid, additional, Faroux, Roger, additional, Guimbaud, Rosine, additional, Tougeron, David, additional, Bouche, Olivier, additional, Lecomte, Thierry, additional, Rebischung, Christine, additional, Tournigand, Christophe, additional, Cros, Jerome, additional, Kay, Richard, additional, Hamm, Adam, additional, Gupta, Anu, additional, Bachet, Jean-Baptiste, additional, and El Hariry, Iman, additional

Published
2020
Full Text
View/download PDF

41. Abstract B22: Trybeca-1: A randomized, phase 3 study of eryaspase in combination with chemotherapy versus chemotherapy alone as second-line treatment in patients with pancreatic adenocarcinoma (NCT03665441)

Author

Hammel, Pascal, primary, Berardi, Rosanna, additional, Cutsem, Eric Van, additional, Feliu, Jaime, additional, Greil, Richard, additional, Wasan, Harpreet, additional, Metges, Jean-Philippe, additional, Nygren, Peter, additional, Österlund, Pia, additional, Noel, Marcus, additional, Seufferlein, Thomas, additional, Creemers, Geert-Jan, additional, Gupta, Anu, additional, Salesse, Sophie, additional, Biswas-Baldwin, Nigel, additional, Dion, Hedy, additional, Youssoufian, Hagop, additional, El-Hariry, Iman, additional, and Hidalgo, Manuel, additional

Published
2019
Full Text
View/download PDF

42. Trybeca-1: A randomized, phase 3 study of eryaspase in combination with chemotherapy versus chemotherapy alone as second-line treatment in patients with pancreatic adenocarcinoma (NCT03665441).

Author

Hammel, Pascal, primary, Berardi, Rossana, additional, Van Cutsem, Eric, additional, Feliu, Jaime, additional, Greil, Richard, additional, Wasan, Harpreet Singh, additional, Metges, Jean-Philippe, additional, Nygren, Peter, additional, Osterlund, Pia J., additional, Parner, Vibeke, additional, Seufferlein, Thomas, additional, Gupta, Anu, additional, Salesse, Sophie, additional, Biswasbaldwin, Nigel, additional, Ibrahim, Ayman, additional, Youssoufian, Hagop, additional, El-Hariry, Iman, additional, and Hidalgo, Manuel, additional

Published
2019
Full Text
View/download PDF

44. A phase IIb of eryaspase in combination with gemcitabine or FOLFOX as second-line therapy in patients with metastatic pancreatic adenocarcinoma (NCT02195180).

Author

Hammel, Pascal, primary, Bachet, Jean-Baptiste, additional, El-Hariry, Iman, additional, Portales, Fabienne, additional, Mineur, Laurent, additional, Metges, Jean-Philippe, additional, De La Fouchardiere, Christelle, additional, Louvet, Christophe, additional, El Hajbi, Farid, additional, Faroux, Roger, additional, Guimbaud, Rosine, additional, Tougeron, David, additional, Volet, Julien, additional, Lecomte, Thierry, additional, Tournigand, Christophe, additional, Rebischung, Christine, additional, Berlier, Willy, additional, Gupta, Anu, additional, Cros, Jerome, additional, and Andre, Thierry, additional

Published
2017
Full Text
View/download PDF

47. Expanded Access Program of GRASPA for treatment of patients with acute lymphoblastic leukemia unable to receive other form of L-Asparaginase: A status update (NCT02197650).

Author

Bertrand, Yves, primary, Dombret, Herve, additional, Quesnel, Bruno, additional, Lissandre, Severine, additional, Schmitt, Claudine, additional, Plouvier, Emmanuel, additional, Recher, Christian, additional, Poiree, Maryline, additional, DUMESNIL de MARICOURT, Cecile, additional, and El-Hariry, Iman, additional

Published
2016
Full Text
View/download PDF

48. Geographic variation in human papillomavirus-related oropharyngeal cancer: Data from 4 multinational randomized trials

Author

Mehanna, Hisham, primary, Franklin, Natalie, additional, Compton, Natalie, additional, Robinson, Max, additional, Powell, Ned, additional, Biswas-Baldwin, Nigel, additional, Paleri, Vindh, additional, Hartley, Andrew, additional, Fresco, Lydia, additional, Al-Booz, Hoda, additional, Junor, Elizabeth, additional, El-Hariry, Iman, additional, Roberts, Sally, additional, Harrington, Kevin, additional, Ang, K. Kian, additional, Dunn, Janet, additional, and Woodman, Ciaran, additional

Published
2016
Full Text
View/download PDF

49. Postoperative Adjuvant Lapatinib and Concurrent Chemoradiotherapy Followed by Maintenance Lapatinib Monotherapy in High-Risk Patients With Resected Squamous Cell Carcinoma of the Head and Neck: A Phase III, Randomized, Double-Blind, Placebo-Controlled Study

Author

Harrington, Kevin, primary, Temam, Stephane, additional, Mehanna, Hisham, additional, D'Cruz, Anil, additional, Jain, Minish, additional, D'Onofrio, Ida, additional, Manikhas, Georgy, additional, Horvath, Zsuzsanna, additional, Sun, Yan, additional, Dietzsch, Stefan, additional, Dubinsky, Pavol, additional, Holeckova, Petra, additional, El-Hariry, Iman, additional, Franklin, Natalie, additional, Biswas-Baldwin, Nigel, additional, Legenne, Philippe, additional, Wissel, Paul, additional, Netherway, Thelma, additional, Farrell, John, additional, Ellis, Catherine, additional, Wang-Silvanto, Jing, additional, Amonkar, Mayur, additional, Ahmed, Nazma, additional, Santillana, Sergio, additional, and Bourhis, Jean, additional

Published
2015
Full Text
View/download PDF

50. Expanded Access Program of Graspa for Treatment of Patients with Acute Lymphoblastic Leukemia Unable to Receive Other Form of L-Asparaginase - a Status Update (NCT02197650)

Author

Bertrand, Yves, primary, Dombret, Hervé, additional, Quesnel, Bruno, additional, Stephan, Jean-Louis, additional, Schmitt, Claudine, additional, Lissandre, Severine, additional, Poiree, Maryline, additional, Recher, Christian, additional, Plouvier, Emmanuel, additional, Dumesnil de Maricourt, Cécile, additional, Salako, David, additional, Godfrin, Yann, additional, and El Hariry, Iman, additional

Published
2015
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results